<乌鸦传媒>Combination Therapy Achieves High Response in Ph+ ALL Ponatinib-blinatumomab offers promising regimen in frontline and relapse/refractory disease Jun 05, 2021
<乌鸦传媒>Small PFS Bump in Synovial Sarcoma With Novel Drug But questions raised over control arm and whether improvement represents a meaningful benefit Jun 05, 2021
<乌鸦传媒>Radioligand Therapy Boosts Survival in Metastatic CRPC PSMA-directed agent improved overall survival by median 4 months Jun 04, 2021
<乌鸦传媒>Adding Chemo to Standard Care No Help for Cervical Cancer Similar OS, PFS, and patterns of recurrence, with more toxicity Jun 04, 2021
<乌鸦传媒>With Supplements, ADT in Prostate Cancer of Little Threat to Bone Density Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
<乌鸦传媒>PD-1 Inhibitor Shows Benefit in Nasopharyngeal Cancer Toripalimab plus first-line chemo improved survival in recurrent/metastatic disease Jun 03, 2021
<乌鸦传媒>Olaparib Wins in Early BRCA-Mutant Breast Cancer First trial to show adjuvant PARP inhibitor benefit inBRCA mutation carriers Jun 03, 2021
<乌鸦传媒>Survival Boost With First-Line Immunotherapy for Esophageal Cancer Nivolumab plus ipilimumab or chemo offers new option for advanced, metastatic disease Jun 03, 2021
<乌鸦传媒>'A Quantum Leap Forward': Potential New Standard in High-Risk RCC Adjuvant immunotherapy led to 32% reduction in the risk of recurrence, positive trend in OS Jun 03, 2021
<乌鸦传媒>Charles Grodin's Death From Multiple Myeloma A look at the beloved actor's highly treatable but rarely curable disease Jun 02, 2021
<乌鸦传媒>First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancer Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes Jun 02, 2021
<乌鸦传媒>Radiation Speeds Up Biological Aging in Head and Neck Cancer Epigenetic age acceleration linked with greater inflammation and fatigue Jun 01, 2021
<乌鸦传媒>Bevacizumab Misses Mark in Untreated Metastatic Bladder Cancer No improvement in overall survival when added to cisplatin-containing chemotherapy Jun 01, 2021
<乌鸦传媒>Drug to Delay T1D Gets Tepid Endorsement by FDA Advisors Feelings mixed on safety and efficacy evidence for novel biologic May 28, 2021
<乌鸦传媒>Hospital at Home May Reduce Hospitalization, Costs for Cancer Patients Study demonstrated efficacy, cost-effectiveness of providing hospital-level services at home May 26, 2021
<乌鸦传媒>Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<乌鸦传媒>Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
<乌鸦传媒>Potassium Acid Blocker No Better Than PPI for Artificial Gastric Ulcers Small Japanese trial found similar outcomes with both drugs May 25, 2021
<乌鸦传媒>Op-Ed: A Door Opens to Transform Cancer Care Incoming CMS Administrator Chiquita Brooks-LaSure brings hope to the cancer community May 25, 2021
<乌鸦传媒>Family Alleges Profit Motives Played Role in 3-Year-Old's Death Parents charge care delays for child with hydrocephalus were tied to arrangements for star doctor May 25, 2021
<乌鸦传媒>Test Can Predict Death Risk With Adrenal Tumors This can help guide need for surgical intervention, researcher says May 24, 2021
<乌鸦传媒>Ovarian Cancer Screening Trial Still Sees No Death Reduction Researchers "disappointed" by long-term results of U.K. study of 200,000 postmenopausal women May 22, 2021
<乌鸦传媒>RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
<乌鸦传媒>Anti-PD-L1 Plus SBRT Enhances Major Responses in Early NSCLC Neoadjuvant combo needs to be validated in a larger randomized trial May 20, 2021
<乌鸦传媒>Vaccination, Screening Succeeds in Cervical and Prostate Cancers Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
<乌鸦传媒>PD-L1 Inhibitor Thwarts Recurrence in Early Lung Cancer Risk of death, recurrence 34% lower with atezolizumab after surgery and chemo May 19, 2021
<乌鸦传媒>Novel Immunotherapy Boosts Melanoma Outcomes Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
<乌鸦传媒>Breast Cancer and MS: New Data Shed Light on Survival Study compares breast cancer patients with and without MS May 19, 2021
<乌鸦传媒>CHS Sues Thousands of Patients; Hospital Parking Fees Under Fire; Trump-Era Emails This past week in healthcare investigations May 19, 2021
<乌鸦传媒>Imiquimod Spurs Regression of High-Grade Cervical Lesions Application of topical cream followed by LEEP benefited patients more than LEEP alone May 17, 2021
<乌鸦传媒>How Did a Patient Survive a Decade With Metastatic RCC? Surgery had beneficial role May 17, 2021
<乌鸦传媒>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<乌鸦传媒>SRS Proves Promising for Brainstem Metastases Results comparable to stereotactic radiosurgery for non-brainstem brain mets May 14, 2021
<乌鸦传媒>Impressive Disease Control in Metastatic Triple-Negative Breast Cancer ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate May 14, 2021
<乌鸦传媒>Chemo-Free Regimen Shows Promise in High-Risk Early Breast Cancer PFS and other outcomes with letrozole-palbociclib almost identical to chemotherapy May 12, 2021
<乌鸦传媒>Combo Therapy Boosts Response in Hairy Cell Leukemia Complete response achieved in 26 of 30 patients with vemurafenib/rituximab May 12, 2021
<乌鸦传媒>Impressive Results With Lenvatinib in Challenging Tumors Multitargeted TKI achieves strong ORR in advanced gastroenteropancreatic NETs May 10, 2021
<乌鸦传媒>No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
<乌鸦传媒>Doubling Down on Immunotherapy in Advanced Melanoma Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
